Celljevity’s 1,000-Patient Milestone: What the Safety Data Tells Us
Clinical safety data is most meaningful when it represents substantial patient experience. Early-phase trials with small numbers of patients can suggest a safety profile, but confidence in that profile grows substantially as the number of treated patients increases and the follow-up period extends. Celljevity’s safety record — zero serious adverse events across more than 1,000 […]